Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Non-Current Assets: 2021-2025

Historic Non-Current Assets for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $15,219.

  • ProQR Therapeutics N.V's Non-Current Assets fell 4.01% to $15,219 in Q3 2025 from the same period last year, while for Sep 2025 it was $15,219, marking a year-over-year decrease of 4.01%. This contributed to the annual value of $15.1 million for FY2024, which is 17.49% down from last year.
  • ProQR Therapeutics N.V's Non-Current Assets amounted to $15,219 in Q3 2025, which was up 1.41% from $15,008 recorded in Q2 2025.
  • Over the past 5 years, ProQR Therapeutics N.V's Non-Current Assets peaked at $22.6 million during Q2 2021, and registered a low of $14,314 during Q1 2025.
  • For the 3-year period, ProQR Therapeutics N.V's Non-Current Assets averaged around $6.6 million, with its median value being $17,537 (2024).
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 88,074.70% in 2022, then plummeted by 99.92% in 2024.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Non-Current Assets stood at $20.7 million in 2021, then decreased by 16.90% to $17.2 million in 2022, then grew by 5.68% to $18.2 million in 2023, then crashed by 99.92% to $15,081 in 2024, then declined by 4.01% to $15,219 in 2025.
  • Its Non-Current Assets stands at $15,219 for Q3 2025, versus $15,008 for Q2 2025 and $14,314 for Q1 2025.